RESEARCH SUMMARY

Remote education program improves carbohydrate counting but not blood sugar control in youth with type 1 diabetes

Moderate confidence
Some Concerns bias
Last updated May 7, 2026

Key takeaway:

A 6-month study in 46 children and adolescents with type 1 diabetes found that a remote multiprofessional educational program improved adherence to carbohydrate counting but did not significantly improve HbA1c or quality of life.

Study at a glance

Study type

RCTs

duration

Medium-Term (3–12 mo)

Intervention

Remote Educational Program

Outcomes

HbA1c, Quality of life, Time in range, Treatment adherence

Funding

Non-industry sponsored

What was studied

Remote education's effect on quality of life and glycemic control in T1D youth

What they found

  • ↑ Carbohydrate counting adherence significantly increased in the intervention group (p<0.001)
  • → HbA1c showed no significant change between groups (IG: 8.9%→9.4%, CG: 9.4%→9.6%)
  • → Quality of life showed no significant difference between groups

mainEffects

↑ Carbohydrate counting adherence significantly increased in the intervention group (p<0.001)

→ HbA1c showed no significant change between groups (IG: 8.9%→9.4%, CG: 9.4%→9.6%)

→ Quality of life showed no significant difference between groups

Evidence Suggest

  • Remote multiprofessional education improves carbohydrate counting adherence in youth with type 1 diabetes
  • Short-term remote education alone may be insufficient to improve glycemic control in children with suboptimal HbA1c
  • Girls and parents/caregivers report lower quality of life, suggesting the need for targeted support

Who this applies to

Children and adolescents aged 1-18 years with type 1 diabetes and suboptimal glycemic control (HbA1c above recommended levels). Results are most relevant to similar populations in Brazil and other Latin American settings.

Keep in Mind

This was a small, open-label study with relatively short follow-up. The findings may not apply to youth with well-controlled diabetes, those using insulin pumps, or populations in settings with different healthcare infrastructure. Both groups received CGM, which may have reduced the apparent benefit of the educational program.

Between the Lines

  • Small sample size (n=46) limits statistical power for subgroup analyses
  • Open-label design introduces potential bias for subjective outcomes (quality of life)
  • CGM provided to both groups may have diluted the measurable intervention effect
  • Short 6-month follow-up may be insufficient to observe metabolic improvements

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Sources

guidelines

ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents

The International Society for Pediatric and Adolescent Diabetes (ISPAD) clinical practice guidelines provide evidence-based recommendations for the diagnosis, staging, and management of type 1 diabetes in children and adolescents, including glycemic targets used in this study.
guidelines

Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range

The international consensus on time in range (Battelino et al., 2019) establishes clinical targets for CGM-derived metrics including time in range >70%, time below range <4%, and time above range <25%, which were used as reference standards in this study.
guidelines

Episode 59: Early Detection of Type 1 Diabetes | American Association of Clinical Endocrinology

This podcast discusses the growing prevalence of Type 1 Diabetes (T1D), the importance of autoantibody screening, the different stages of T1D, screening guidelines, patient counseling, and how early intervention can help delay progression and reduce complications.
guidelines

Standards of Care in Diabetes—2024

Annual ADA clinical practice guideline issue covering broad diabetes management.
guidelines

2015 Consensus Statement on Midgut Carcinoids | American Association of Clinical Endocrinology

Carcinoid tumors, which most commonly originate from the small intestine, are either referred to as small intestinal neuroendocrine tumors or midgut carcinoids. This statement addresses diagnostics and therapeutics for patients with midgut carcinoids and provides an overview of multidisciplinary care to improve quality of life, treatment outcomes, and survival.
guidelines

2021 Clinical Practice Guideline for the Use of Advanced Technology in the Management of Persons with Diabetes Mellitus | American Association of Clinical Endocrinology

Advanced diabetes technology can potentially assist persons with diabetes to achieve glycemic targets, improve quality of life, reduce burden of care, offer a personalized approach to self-management, and improve the efficiency of clinical decision-making, among other benefits. This guideline provides recommendations on the efficacy and safety of advanced diabetes technology devices for management of persons with diabetes mellitus, metrics used to aide with the assessment of advanced diabetes technology, and standards for implementation of this technology.
guidelines

CGM & Time in Range | American Diabetes Association

Understand the benefits of time in range (TIR) with continuous glucose monitors. Compare TIR vs A1C to better manage your blood glucose levels for a healthier lifestyle.
healthAuthorities

IDF Diabetes Atlas 2021

The International Diabetes Federation Diabetes Atlas provides global and regional estimates of diabetes prevalence and impact, documenting Brazil as the third-ranked country for individuals under 20 with type 1 diabetes.
studiesGroup

Automated Insulin Delivery Systems and Glucose Management in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-Analysis.

2025
studiesGroup

Digital Health Interventions in Children and Adolescents With Type 1 Diabetes Mellitus and Their Impact on Clinical and Behavioral Outcomes: Scoping Review.

2026
studiesGroup

Health-related quality of life, glycaemic control, lifestyle characteristics and SARS-CoV-2 prevalence in children with type 1 diabetes during the COVID-19 pandemic: results of a longitudinal, prospective single-centre Swiss study.

2026
studiesGroup

Impact of technologies on quality of life in relation to glucose control in patients with type 1 diabetes.

2026
studiesGroup

Emotional Well-Being and Glycemic Control in People with Diabetes After a Multidisciplinary Hybrid Education.

2026

No ads. No tracking

A clean, privacy-first research experience.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.